Evolution Wealth Advisors, LLC - ASCENDIS PHARMA A/S ownership

ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 173 filers reported holding ASCENDIS PHARMA A/S in Q2 2021. The put-call ratio across all filers is 4.45 and the average weighting 0.4%.

Quarter-by-quarter ownership
Evolution Wealth Advisors, LLC ownership history of ASCENDIS PHARMA A/S
ValueSharesWeighting
Q3 2021$14,000
-50.0%
88
-58.3%
0.00%
-50.0%
Q2 2021$28,000
+3.7%
2110.0%0.01%0.0%
Q1 2021$27,000
-20.6%
211
+3.9%
0.01%
-25.0%
Q4 2020$34,000
-5.6%
203
-14.0%
0.01%
-20.0%
Q3 2020$36,000
+16.1%
236
+11.8%
0.01%0.0%
Q2 2020$31,000
+24.0%
211
-6.6%
0.01%0.0%
Q1 2020$25,000
-3.8%
226
+18.9%
0.01%
+42.9%
Q4 2019$26,0001900.01%
Other shareholders
ASCENDIS PHARMA A/S shareholders Q2 2021
NameSharesValueWeighting ↓
RA Capital Management 10,719,555$1,003,779,13019.76%
Q Global Advisors, LLC 285,000$26,68717.16%
Finepoint Capital LP 163,772$15,335,6107.64%
Avoro Capital Advisors LLC 3,670,000$343,658,8005.36%
Spyglass Capital Management LLC 614,618$57,552,8304.51%
Sofinnova Investments, Inc. 754,032$70,607,5564.45%
Saturn V Capital Management LP 112,473$10,531,9724.41%
DAFNA Capital Management LLC 136,212$12,754,8923.97%
ARS Investment Partners, LLC 285,918$26,773,3623.32%
Ghost Tree Capital, LLC 85,000$7,959,4002.62%
View complete list of ASCENDIS PHARMA A/S shareholders